2018-Present

MISSION

SWHR’s Interdisciplinary Network on Estrogen-Driven Diseases brings together clinicians, researchers, patients, and health care decision-makers to provide thought leadership on how to address the gaps in research, diagnosis, treatment, and care for endometriosis, uterine fibroids, and related conditions and symptoms.

The goals of the network are to:

  1. Identify unmet needs and articulate necessary incentives to drive innovation in research, diagnosis, and treatment for estrogen-driven diseases.

  2. Engage and inform patients, health care professionals and providers, payers, policymakers, and employers about the patient experience, disease burden, stigma, and impact to society.

  3. Develop strategies and materials to inform and impact value-driven decision-making about estrogen-driven diseases in diagnosis, treatment, and access to care.

BACKGROUND

An estimated 10% of reproductive-age women are living with endometriosis, a condition in which tissue that resembles that of the lining of the uterus grows outside the uterus, leading to lesions, heavy bleeding, and painful periods. (For a quick overview of endometriosis, check out SWHR’s fact sheet.) About 26 million women suffer from uterine fibroids, a condition in which benign tumors growing in and around the uterus cause heaving and irregular bleeding, anemia, and painful periods. Both diseases can cause severe and debilitating pelvic pain and problems with fertility, significantly impacting the lives of the women with these conditions. The normalization of women’s pain and the stigmatization of menstrual issues have resulted in a lack of scientific innovation and public awareness for many diseases and conditions that disproportionately impact women.

PROGRAM DIRECTOR

Sherie Lou Santos, MPH
SWHR Director of Science Policy
science@swhr.org

NETWORK MEMBERS

Network members will be announced soon.

OUR WORK

Expert Review

Assessing Research Gaps and Unmet Needs in EndometriosisAmerican Journal of Obstetrics and Gynecology

Media Coverage

Endometriosis Roundtable and Public Forum

SWHR convened a group of researchers, clinicians, patients, and other stakeholders for a one-day roundtable meeting and public forum on April 10, 2018, to identify unmet needs and knowledge gaps in endometriosis, and explore the best means to further research, expand diagnostic and treatment options, and improve disease awareness and identification. Read more about the public forum.

Congressional Briefing

On June 19, 2018, SWHR held a congressional briefing, “Endometriosis: Erasing Stigma, Improving Patient Care,” during which a panel of experts addressed the current state of endometriosis research as well as policy solutions to improve a woman’s diagnosis, treatment, and access to care. Read more about the congressional briefing.

Policy Engagement

SWHR submitted comments to the Institute for Clinical and Economic Review (ICER) on the assessment of effectiveness and value of new therapies for endometriosis on February 1, 2018, and May 31, 2018.

LATEST NEWS


Identifying Barriers to Care for Women With Endometriosis

An SWHR working group published an expert review in the American Journal of Obstetrics and Gynecology that identifies areas of need to improve a woman’s diagnosis, treatment, and access to quality care, as well as highlights priorities for the future of endometriosis research and care.

 


Spurring Innovation in Endometriosis Through Policy Changes

Despite its prevalence and potentially severe effects on women, their families, and society, endometriosis is not well known or well understood. SWHR hosted a congressional briefing on June 19 to discuss the current state of endometriosis research as well as identify policy needs to improve a woman’s diagnosis, treatment, and access to care.

SWHR has sole authority over the scope and content of this program. Sponsorship of this network does not imply agreement with any content and/or comments presented by the members during network proceedings.

Sponsors